The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

OBJECTIVE: Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster, and vaccination is recommended for patients ages 50 years and older, prior to starting treatment with biologic agents or tofacitinib. Tofacitinib is an oral JAK inhibitor for the treatment of RA. We evaluated...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Arthritis Rheumatol
Main Authors: Winthrop, Kevin L., Wouters, Ann G., Choy, Ernest H., Soma, Koshika, Hodge, Jennifer A., Nduaka, Chudy I., Biswas, Pinaki, Needle, Elie, Passador, Sherry, Mojcik, Christopher F., Rigby, William F.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2017
Fag:
Rheumatoid Arthritis
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656925/
https://ncbi.nlm.nih.gov/pubmed/28845577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40187
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker